Cost-effectiveness of topical 0.03% flurbiprofen in outpatient cataract surgery as measured by surgical time and vitreous loss

American Journal of Health-System Pharmacy

Volumn 55, Issue 24 SUPPL., 1998, Pages

  Gaynes, Bruce I ^a   Deutsch, Thomas A ^a  

^a RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLURBIPROFEN;

ADOLESCENT; ADULT; AGED; AMBULATORY SURGERY; CATARACT; CATARACT EXTRACTION; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DRUG COST; HEALTH CARE COST; HOSPITAL COST; HUMAN; MAJOR CLINICAL STUDY; OPERATION DURATION; PHACOEMULSIFICATION; PRIORITY JOURNAL; SCHOOL CHILD; TOPICAL DRUG ADMINISTRATION; VITRECTOMY;

EID: 0032535402     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/55.suppl_4.s23     Document Type: Conference Paper

References (2)

1. Stjernschantz J. Autacoids and neuropeptides. In: Sears ML, ed. Handbook of experimental pharmacology. Vol. 69. Pharmacology of the eye. New York: Springer-Verlag; 1984:312-29.
2. Solomon KD, Turkalj JW, Whiteside SB et al. Topical 0.5% ketorolac vs 0.03% flurbiprofen for inhibition of miosis during cataract surgery. Arch Ophthalmol. 1997; 115:1119-22.